RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Blade, Cortex doesn't usually have quarterly conf calls, unless there's been some big news to discuss. The regular annual SHM presentation should be in ~ May (last year was May 14).

Well, I guess there just hasn't been that much demand out there for partnering RD/CX-717, at least not without including CX-1739 and/or Sleep Apnea. I was hoping it might at least bring a $5 mil upfront.

Pharmas are probably being inundated right now with partnering proposals from desperate small caps, so there's a lot of competition. I still think designing a pivotal RD trial could look daunting to potential partners. SA will have a much broader appeal. There will be alot riding on these SA results (an understatement). Should keep things interesting :o)